Insights

Gathering insights about IconOVir Bio…

Similar companies to IconOVir Bio

IconOVir Bio Tech Stack

IconOVir Bio uses 8 technology products and services including QuickBooks, WordPress, MySQL, and more. Explore IconOVir Bio's tech stack below.

QuickBooks
Accounting And Finance
WordPress
Content Management System
MySQL
Database
Shopify
E-commerce
Microsoft 365
Email
jQuery
Javascript Libraries
Swiper
Javascript Libraries
X-XSS-Protection
Security

Media & News

IconOVir Bio, Inc. sells assets to UroGen Pharma, Inc. in the amount of $4M.
IconOVir, 4 years on from flashy launch, sells oncolytic virus to UroGen for $4M in stock.
Feb 20, 2025 | www.fiercebiotech.com
IconOVir Bio, Inc. launches ICVB-1042.
IconOVir Bio announces first patient dosed in Phase 1 Clinical Trial of its lead product candidate, ICVB-1042.
Jul 11, 2023 | www.businesswire.com
IconOVir Bio, Inc. launched preclinical data demonstrating proof-of-concept for lead program ICVB-1042 on Nov 10th '22.
IconOVir Bio, Inc. (IconOVir), a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus (OV) therapy to improve the treatment of patients with cancer, today announced new preclinical data demonstrating proof-of-concept for its lead program ICVB-1042.
Nov 10, 2022 | www.businesswire.com
Bellcocapital invested into IconOVir Bio, Inc. on Jan 1st '21.
In January 2021, the life science-focused family office Bellco Capital invested in IconOVir.
Oct 18, 2022 | familyofficehub.io
IconOVir Bio, Inc. hired Maltzman as Franchise Head, Vice President and Global Head of Gastrointestinal on Sep 10th '22.
Dr. Maltzman joins IconOVir from Genentech, where she most recently served as Franchise Head, Vice President and Global Head of Gastrointestinal (GI) and Cancer Immunotherapy.
Oct 10, 2022 | www.businesswire.com
IconOVir Bio, Inc. hired Julia (Julie) Maltzman as Chief Medical Officer on Oct 10th '22.
IconOVir Bio, Inc. (IconOVir), a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus (OV) therapy to improve the treatment of patients with cancer, today announced the appointment of Julia (Julie) Maltzman, M.D., as its Chief Medical Officer.
Oct 10, 2022 | www.businesswire.com
IconOVir Bio, Inc. hires William as Board of Directors.
IconOVir Bio appoints William kaelin, jr., M.D., to Board of Directors.
Jun 22, 2022 | iconovir.com

IconOVir Bio's Email Address Formats

IconOVir Bio uses at least 1 format(s):

IconOVir Bio Email Formats	Example	Percentage
First.Last@iconovir.com	John.Doe@iconovir.com	69%
FLast@iconovir.com	JDoe@iconovir.com	18%
Last@iconovir.com	Doe@iconovir.com	7%
First@iconovir.com	John@iconovir.com	6%

Frequently Asked Questions

Where is IconOVir Bio's headquarters located?

IconOVir Bio's main headquarters is located at 4570 Executive Drive, Suite 350. The company has employees across 1 continents, including North America.

What is IconOVir Bio's official website and social media links?

IconOVir Bio's official website is iconovir.com and has social profiles on LinkedIn Crunchbase.

What is IconOVir Bio's SIC code NAICS code?

IconOVir Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does IconOVir Bio have currently?

As of December 2025, IconOVir Bio has approximately 11 employees across 1 continents, including North America. Key team members include Chief Technology Officer: J. H.Controller & Treasurer: S. A.Principal: J. C.. Explore IconOVir Bio's employee directory with LeadIQ.

What industry does IconOVir Bio belong to?

IconOVir Bio operates in the Biotechnology Research industry.

What technology does IconOVir Bio use?

IconOVir Bio's tech stack includes QuickBooksWordPressMySQLShopifyMicrosoft 365jQuerySwiperX-XSS-Protection.

What is IconOVir Bio's email format?

IconOVir Bio's email format typically follows the pattern of First.Last@iconovir.com. Find more IconOVir Bio email formats with LeadIQ.

How much funding has IconOVir Bio raised to date?

As of December 2025, IconOVir Bio has raised $77M in funding. The last funding round occurred on Jan 05, 2021 for $77M.

IconOVir Bio

Q: What is IconOVir Bio's official website and social media links?

IconOVir Bio's official website is iconovir.com. IconOVir Bio has social profiles on LinkedIn.

Q: How many employees does IconOVir Bio have currently?

IconOVir Bio has approximately 11 employees.

Q: What technology does IconOVir Bio use?

IconOVir Bio's tech stack includes Apache, WordPress, RankMath SEO, QuickBooks, Nginx.

Biotechnology ResearchCalifornia, United States11-50 Employees

IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O’Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.

Company Overview

Headquarters: 4570 Executive Drive, Suite 350
Website: iconovir.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 11-50

Media & News

Funding & Financials

$77M
IconOVir Bio has raised a total of $77M of funding over 1 rounds. Their latest funding round was raised on Jan 05, 2021 in the amount of $77M.
$1M$10M
IconOVir Bio's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$77M
IconOVir Bio has raised a total of $77M of funding over 1 rounds. Their latest funding round was raised on Jan 05, 2021 in the amount of $77M.
$1M$10M
IconOVir Bio's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to IconOVir Bio

Pyxis Oncology

Evelo Biosciences

Synlogic, Inc.

TargEDys

Lohocla Research Corporation

IconOVir Bio Tech Stack

Media & News

IconOVir Bio, Inc. sells assets to UroGen Pharma, Inc. in the amount of $4M.

IconOVir Bio, Inc. launches ICVB-1042.

IconOVir Bio, Inc. launched preclinical data demonstrating proof-of-concept for lead program ICVB-1042 on Nov 10th '22.

Bellcocapital invested into IconOVir Bio, Inc. on Jan 1st '21.

IconOVir Bio, Inc. hired Maltzman as Franchise Head, Vice President and Global Head of Gastrointestinal on Sep 10th '22.

IconOVir Bio, Inc. hired Julia (Julie) Maltzman as Chief Medical Officer on Oct 10th '22.

IconOVir Bio, Inc. hires William as Board of Directors.

IconOVir Bio's Email Address Formats

Frequently Asked Questions

Where is IconOVir Bio's headquarters located?

What is IconOVir Bio's official website and social media links?

What is IconOVir Bio's SIC code NAICS code?

How many employees does IconOVir Bio have currently?

What industry does IconOVir Bio belong to?

What technology does IconOVir Bio use?

What is IconOVir Bio's email format?

How much funding has IconOVir Bio raised to date?

IconOVir Bio

Company Overview

Media & News

IconOVir Bio, Inc. sells assets to UroGen Pharma, Inc. in the amount of $4M.

IconOVir Bio, Inc. launches ICVB-1042.

IconOVir Bio, Inc. launched preclinical data demonstrating proof-of-concept for lead program ICVB-1042 on Nov 10th '22.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?